Pasithea Therapeutics (KTTA) Shares Outstanding (2020 - 2026)

Pasithea Therapeutics has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $24.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 1027.89% year-over-year to $24.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 million (up 1027.89% YoY) and the FY2025 annual result came in at $7.0 million, up 541.47% from the prior year.
• Shares Outstanding (Entity) climbed to $24.9 million in Q1 2026 per KTTA's latest filing, from $7.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $24.9 million in Q1 2026 and troughed at $1.0 million in Q4 2023.
• A 5-year average of $3.6 million and a median of $1.3 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) fell 21.52% in 2023, then jumped 1027.89% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $1.3 million in 2022, then declined by 20.01% to $1.0 million in 2023, then rose by 5.23% to $1.1 million in 2024, then soared by 541.47% to $7.0 million in 2025, then soared by 254.71% to $24.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $24.9 million, $7.0 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.